Angiogenesis and gene therapy in man. Dream or reality?

Drugs

Volumn 58, Issue SPEC.ISS. 1, 1999, Pages 33-36

  Amant, C ^a   Berthou, L ^a   Walsh, Kenneth ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; RECOMBINANT PROTEIN; VASCULOTROPIN; VIRUS VECTOR; ANGIOGENIC FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN A;

ANGIOGENESIS; ARTERY DISEASE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HUMAN; INTRACARDIAC DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PLASMID; SAFETY; VASCULAR ENDOTHELIUM; ANIMAL; COLLATERAL CIRCULATION; DRUG EFFECT; GENE VECTOR; ISCHEMIA; PATHOPHYSIOLOGY; REVIEW;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CLINICAL TRIALS; GENE THERAPY; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; COLLATERAL CIRCULATION; ENDOTHELIAL GROWTH FACTORS; GENETIC VECTORS; ISCHEMIA; LYMPHOKINES; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0032665620     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol 1987; 49: 453-64
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6
3. Baffour R, Berman J, Garb JL, et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vase Surg 1992; 16 (2): 181-91
4. Pu LQ, Sniderman AD, Brassard R, et al. Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 1993; 88: 208-15
5. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70
6. Hariawala M, Horowitz JR, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 1996; 63: 77-82
7. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995; 1: 1085-9
8. French BA, Mazur W, Ali NM, et al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 1994; 90 (5): 2402-13
9. Isner JM, Walsh K, Symes J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease [news]. Circulation 1995; 91: 2687-92
10. 165 in patient with ischaemic limb Lancet 1996; 348: 370-4
11. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8
12. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-23
13. Tio R, Lebherz C, Scheuermann T, et al. Intramyocardial injection with naked DNA encoding for VEGF causes local and systemic production of VEGF, and improves collateral flow to ischemic myocardial tissue [abstract no. 2767]. Circulation 1998; 98 (Suppl.)
14. 165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-4
15. 121 cDNA adenovirus-mediated angiogenesis gene therapy in conjunction with coronary bypass surgery [abstract no. 1684]. Circulation 1998; 98 (Suppl.)